Form 4: Ginkgo Bioworks CFO Mark Dmytruk Reports Stock Transactions

CFO Mark Dmytruk reports transactions involving Ginkgo Bioworks Class A and Class B common stock, including acquisitions from RSU vesting and a sale to cover tax obligations.

Summary

• Mark Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., reported several transactions involving the company's Class A and Class B common stock.
• On April 17, 2025, Dmytruk acquired shares of Class A Common Stock through the vesting of Restricted Stock Units (RSUs).
• Specifically, 454, 453, 572, and 1,061 shares were acquired from RSU vesting.
• Additionally, 8 shares of Class A Common Stock were acquired through the conversion of Class B Common Stock.
• On April 21, 2025, Dmytruk sold 1,244 shares of Class A Common Stock at a price of $7.283 per share.
• This sale was to cover tax withholding obligations related to the vesting of restricted stock and/or restricted stock units.
• Following these transactions, Dmytruk directly owns 45,453 shares of Class A Common Stock and 5,906 shares of Class B Common Stock.
• The Class B Common Stock is convertible to Class A Common Stock on a one-to-one basis.

Sentiment

Score: 5

Explanation: The document is neutral in sentiment as it simply reports stock transactions. There is no indication of positive or negative sentiment.

Positives

• The vesting of RSUs indicates that Dmytruk is meeting certain performance or time-based milestones set by the company.
• The conversion of Class B shares to Class A shares does not have a negative impact.

Negatives

• The sale of shares to cover tax obligations, while routine, slightly reduces Dmytruk's holdings in the company.

Risks

• There are no specific risks highlighted in this document.
• However, insider sales can sometimes be perceived negatively by the market, even when they are for routine purposes like covering tax obligations.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders. It provides transparency into the transactions of company executives and their holdings in the company.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies and their insiders.
• The transactions reported are typical for executives who receive stock-based compensation and need to manage their tax obligations.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on stakeholders.

Key Dates

Keywords

Ginkgo Bioworks, Dmytruk, Insider Trading, Form 4, RSU, Class A Common Stock, Class B Common Stock, Tax Withholding, Vesting, DNA